• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS-300M-K - FGI
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Discomfort (2330); Neck Pain (2433)
Event Date 05/10/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient was implanted with the rns system including four depth leads dl-344-10, port 1, left mesial temporal (suspected lead break).Dl-330-10, port2, right mesial temporal dl-330-10, right para-hippocampus, not connected.Dl-344-10, left para hippocampus, not connected.Product remains implanted.
 
Event Description
The patient reports a shocking sensation and muscle tightening in the neck whenever the device delivers therapy.He was on a lead-to-lead (l hippocampus - r hippocampus) therapy pathway at 2.8 uc (burst 1) and 2.5 uc (burst 2) current density.The patient reported that he experienced a shocking sensation when the device delivered therapy and when interrogating, this has been occurring since (b)(6) 2014, when therapy was activated.The site performed blinded therapy testing during clinic that corroborated the patient's experience when stimulation is delivered.The polarity was changed, this seemed to make the shocking sensation go away during therapy testing.Patient states he can still feel the shocking sensation when he interrogates but no longer randomly throughout the day, when he is likely receiving therapy.(b)(6) 2017 follow-up appointment attended by company representative dr.(b)(6) performed the unipolar study on the 4 electrodes on lead 2 (rh) to test which electrode(s) give the "shocking" sensation.Electrode 1 - felt sensation 50% of testing.Electrode 2 - no sensation.Electrode 3 - no sensation.Electrode 4 - no sensation.Electrode 1 was taken out of the therapy pathway.Electrodes 2, 3, and 4 were programmed negative to the can (0 - - -) (+).Patient did not report feeling the sensation during therapy testing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key6629718
MDR Text Key77277654
Report Number3004426659-2017-00024
Device Sequence Number1
Product Code PFN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 05/31/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberRNS-300M-K - FGI
Device Catalogue Number1007427
Device Lot Number18426-1-1-1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age27 YR
-
-